ABSTRACT
Alcohol misuse during adolescence (AAM) has been linked with disruptive structural development of the brain and alcohol use disorder. Using machine learning (ML), we analyze the link between AAM phenotypes and adolescent brain structure (T1-weighted imaging and DTI) at ages 14, 19, and 22 in the IMAGEN dataset (n ∼ 1182). ML predicted AAM at age 22 from brain structure with a balanced accuracy of 78% on independent test data. Therefore, structural differences in adolescent brains could significantly predict AAM. Using brain structure at age 14 and 19, ML predicted AAM at age 22 with a balanced accuracy of 73% and 75%, respectively. These results showed that structural differences preceded alcohol misuse behavior in the dataset. The most informative features were located in the white matter tracts of the corpus callosum and internal capsule, brain stem, and ventricular CSF. In the cortex, they were spread across the occipital, frontal, and temporal lobes and in the cingulate cortex. Our study also demonstrates how the choice of the phenotype for AAM, the ML method, and the confound correction technique are all crucial decisions in an exploratory ML study analyzing psychiatric disorders with weak effect sizes such as AAM.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We acknowledge support from the German Research Foundation (DFG, 389563835; 402170461-TRR 265;457414984028-CRC 1404).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Approval was received from IMAGEN to use their data for the present work and a unique registration ID 'edeman' was provided for this project. The ethics committee of King's college London gave ethical approval for the IMAGEN data used in this project.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced are available online at https://github.com/RoshanRane/ML_for_IMAGEN
